News for hackers. Stuff that matters.
Re:AstraZeneca vaccine doesn't prevent B1351 Covid in early ... by kolinko on Wednesday March 17, 2021 @05:48AM (#26488738)
Weird. Are you sure the tweets talk about the same study?

The study in the article didn’t look at antibody response, but at the clinical outcome - just like the original Phase III studies did, just with a smaller group of people.

As for the claim that we don’t know how the vaccine protects from hospitalisations - if there is literally no difference in mild cases, why would there be any difference in severe?

Is there a single vaccine for any disease that offers no protection against mild cases, but a high protection from severe?

Re:AstraZeneca vaccine doesn't prevent B1351 Covid in early ... by 360walk on Wednesday March 17, 2021 @06:58AM (#26489266)
Regarding the question about how the vaccine could protect against severe but not mild infection, I think they answer that here:

> Antibodies can prevent infection, your T cell-responses ensure that those antibodies keep doing their job and they kick in after you're infected OR oh my goodness stop the presses- VACCINATED (how about them apples). In other words, while robust T-cells responses cannot protect you from a mild or moderate infection sometimes (think cough, sniffles, etc.) they can however proliferate rapidly and prevent the build up of viral load. Psst- you want this to be LOW. VL drives disease severity.

Re:AstraZeneca vaccine doesn't prevent B1351 Covid in early ... by MrAlex94 on Wednesday March 17, 2021 @07:19AM (#26489465)
> Weird. Are you sure the tweets talk about the same study?

Yes, this is in reference to B.1.351 and the AZ SA study.